160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I
| Autor: | Ponce Aix, S., Carcereny Costa, E., Bosch-Barrera, J., Felip Font, E., Guirado, M., Coves Sarto, J., Majem Tarruella, M., Juan Vidal, O.J., Dalmau Portulas, E., Diz, P., Ortega Granados, A.L.O., Domine Gomez, M., Blasco Cordellat, A., Mosquera Martinez, J., Sala Gonzalez, M.A., Dorta, M., Calvo de Juan, V., Zugazagoitia, J., Enguita, A.B., Paz-Ares, L. |
|---|---|
| Zdroj: | In Annals of Oncology December 2021 32 Supplement 7:S1450-S1450 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|